BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35611500)

  • 1. Surgical and oncological outcomes of D1 versus D2 gastrectomy among elderly patients treated for gastric cancer.
    Back J; Sallinen V; Kokkola A; Puolakkainen P
    Scand J Surg; 2022; 111(2):14574969221096193. PubMed ID: 35611500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
    Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
    Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study.
    Rausei S; Ruspi L; Rosa F; Morgagni P; Marrelli D; Cossu A; Cananzi FC; Lomonaco R; Coniglio A; Biondi A; Cipollari C; Graziosi L; Fumagalli U; Casella F; Bertoli P; di Leo A; Alfieri S; Vittimberga G; Roviello F; Orsenigo E; Quagliuolo V; Montemurro S; Baiocchi G; Persiani R; Bencivenga M; Donini A; Rosati R; Sansonetti A; Ansaloni L; Zanoni A; Galli F; Dionigi G;
    Eur J Surg Oncol; 2016 Dec; 42(12):1881-1889. PubMed ID: 27266816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching.
    Lam S; Tan E; Menezes A; Martin D; Gallagher J; Storey D; Sandroussi C
    World J Surg Oncol; 2018 Jul; 16(1):136. PubMed ID: 29986713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial.
    Degiuli M; Reddavid R; Tomatis M; Ponti A; Morino M; Sasako M;
    Eur J Cancer; 2021 Jun; 150():10-22. PubMed ID: 33887514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery.
    Kung CH; Tsai JA; Lundell L; Johansson J; Nilsson M; Lindblad M
    BJS Open; 2020 Jun; 4(3):424-431. PubMed ID: 32129948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis.
    Galizia G; Lieto E; De Vita F; Castellano P; Ferraraccio F; Zamboli A; Mabilia A; Auricchio A; De Sena G; De Stefano L; Cardella F; Barbarisi A; Orditura M
    Surgery; 2015 Feb; 157(2):285-96. PubMed ID: 25532433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching.
    Kang JH; Ryu SY; Jung MR; Jeong O
    Eur J Surg Oncol; 2020 Jul; 46(7):1239-1246. PubMed ID: 32331983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of long-term prognosis of laparoscopy-assisted gastrectomy and conventional open gastrectomy with special reference to D2 lymph node dissection.
    Sato H; Shimada M; Kurita N; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Miyatani T; Goto M; Kashihara H; Takasu C
    Surg Endosc; 2012 Aug; 26(8):2240-6. PubMed ID: 22311300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of gastrectomy with lymphadenectomy in gastric cancer.
    Zilberstein B; Martins BC; Jacob CE; Bresciani C; Lopasso FP; de Cleva R; Pinto Junior PE; Junior UR; Perez RO; Gama-Rodrigues J
    Gastric Cancer; 2004; 7(4):254-9. PubMed ID: 15616774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
    Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
    Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
    Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Operative and Oncological Outcomes After D2 Versus D1 Gastrectomy of Operable Gastric Cancer: an Observational Study.
    Elmessiry MM; El-Fayoumi TA; Fayed HM; Gebaly AA; Mohamed EAE
    J Gastrointest Cancer; 2022 Mar; 53(1):91-98. PubMed ID: 33188500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative outcomes and survival in elderly patients aged ≥ 75 years undergoing gastrectomy for gastric cancer: an 18-year retrospective analysis in a single Western centre.
    Tan E; Lam S; Han SP; Storey D; Sandroussi C
    Langenbecks Arch Surg; 2021 Jun; 406(4):1057-1069. PubMed ID: 33770264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total and Subtotal Laparoscopic Gastrectomy for the Treatment of Advanced Gastric Cancer: Morbidity and Oncological Outcomes.
    Olmi S; Giorgi R; Cioffi SPB; Uccelli M; Villa R; Ciccarese F; Scotto B; Castello G; Legnani G; Cesana G
    J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):278-285. PubMed ID: 29135363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of lymph node dissection for adenocarcinoma of the stomach.
    Mocellin S; McCulloch P; Kazi H; Gama-Rodrigues JJ; Yuan Y; Nitti D
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001964. PubMed ID: 26267122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
    Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
    Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
    Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
    J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D2 Lymphadenectomy for Gastric Adenocarcinoma: Long-term Results and the Impact of Surgeon Experience on the Survival Rates.
    Tudor S; Dumitrascu T; Manuc M; Trandafir B; Ionescu M; Popescu I; Herlea V; Vasilescu C
    Chirurgia (Bucur); 2018; 113(6):772-779. PubMed ID: 30596365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.